CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Reports

We found 7005 result(s)

Abatacept (Orencia)

Last Updated: August 29, 2008
Result type: Reports
Product Line: Common Drug Review
Generic Name: Abatacept
Indications: Arthritis, Juvenile Idiopathic & Juvenile Rheumatoid

  • Brand Name: Orencia
  • Manufacturer: Bristol-Myers Squibb Canada
  • Project Number: S0145
  • Project Status: Complete
  • Submission Type: New Indication

Insulin glargine (rDNA origin) (Lantus)

Last Updated: March 27, 2006
Result type: Reports
Product Line: Common Drug Review
Generic Name: Insulin glargine (rDNA origin)
Indications: Diabetes mellitus, Type 1 & 2

  • Brand Name: Lantus
  • Manufacturer: Sanofi-Aventis Canada Inc.
  • Project Number: S0058
  • Project Status: Complete
  • Submission Type: Resubmission

Adalimumab (Humira)

Last Updated: June 21, 2006
Result type: Reports
Product Line: Common Drug Review
Generic Name: Adalimumab
Indications: Arthritis, Psoriatic

  • Brand Name: Humira
  • Manufacturer: Abbott Laboratories Limited
  • Project Number: S0066
  • Project Status: Complete
  • Submission Type: Resubmission

Sorafenib tablets (Nexavar)

Last Updated: July 31, 2006
Result type: Reports
Product Line: Common Drug Review
Generic Name: Sorafenib tablets
Indications: Cancer, Renal cell carcinoma

  • Brand Name: Nexavar
  • Manufacturer: Bayer Inc.
  • Project Number: S0071
  • Project Status: Complete
  • Submission Type: New

Sildenafil citrate (Revatio)

Last Updated: September 20, 2006
Result type: Reports
Product Line: Common Drug Review
Generic Name: Sildenafil citrate
Indications: Pulmonary arterial hypertension (WHO class II and III)

  • Brand Name: Revatio
  • Manufacturer: Pfizer Canada Inc.
  • Project Number: S0076
  • Project Status: Complete
  • Submission Type: New

Histrelin acetate (Vantas)

Last Updated: September 20, 2006
Result type: Reports
Product Line: Common Drug Review
Generic Name: Histrelin acetate
Indications: Cancer, prostate

  • Brand Name: Vantas
  • Manufacturer: Paladin Labs Inc.
  • Project Number: S0078
  • Project Status: Complete
  • Submission Type: New

Ramipril/hydrochlorothiazide (Altace HCT)

Last Updated: October 26, 2006
Result type: Reports
Product Line: Common Drug Review
Generic Name: Ramipril/hydrochlorothiazide
Indications: Hypertension

  • Brand Name: Altace HCT
  • Manufacturer: Sanofi –Aventis Canada inc.
  • Project Number: S0083
  • Project Status: Cancelled
  • Submission Type: New

OnabotulinumtoxinA (Botox)

Last Updated: January 31, 2012
Result type: Reports
Product Line: Common Drug Review
Generic Name: OnabotulinumtoxinA
Indications: Neurogenic Detrusor Overactivity

  • Brand Name: Botox
  • Manufacturer: Allergan Inc.
  • Project Number: SR0268
  • Project Status: Complete
  • Submission Type: New